Glico and Physician Partners helped health test provider Viome raise $54m while real estate data provider CompStak and battery swapping technology developer Ample each bagged $50m.

Funding

Viome Life Sciences, a US-based provider of consumer health tests, secured $54m on Wednesday in a pre-series C convertible note round that included consumer food producer Glico and healthcare provider Physician Partners. They joined Khosla Ventures, West River Group, Ocgrow Ventures and Bold Capital Group in the round, which took Viome’s overall funding to over $125m, it said. The company closed a $56m series B round featuring Physician Partners, Bold Capital, Hambrecht Healthcare Growth Venture Fund and private investors Marc Benioff and Matthew Harris in November 2019. Physician Partners had invested $5m in Viome the previous year.

Property developer Mitsui Fudosan’s 31Ventures unit contributed to a $50m series C round today for CompStak, a US-headquartered provider of data covering commercial real estate deals. The round was led by funds managed by Morgan Stanley Expansion Capital and also featured real estate development and investment firm Crow Holdings and existing…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.